TO-O-1001 & TO-O-1002 won the 2023 R&D 100 Award
《R&D World》magazine has announced the winners of the 2023 R&D 100 awards, the 61-years world-renowned science and innovation competition. TO-O-1001 is a best-in-class ROCKi eye drops for the glaucoma treatment. It has a significant effect of lowering IOP with low side effects. TO-O-1002 has repeatedly won international awards, which shows that its novelty has been recognized by international reviewers, and it will provide a more friendly way for the treatment of nAMD in the future.